| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.15B | 85.93B | 83.38B | 82.85B | 86.42B | 77.52B |
| Gross Profit | 24.85B | 27.20B | 24.15B | 21.98B | 19.83B | 17.03B |
| EBITDA | 4.36B | 4.86B | 4.27B | 3.81B | 2.63B | 1.64B |
| Net Income | 2.78B | 3.67B | 2.63B | 2.08B | 1.01B | 366.57M |
Balance Sheet | ||||||
| Total Assets | 77.28B | 82.63B | 79.20B | 74.07B | 73.03B | 64.70B |
| Cash, Cash Equivalents and Short-Term Investments | 9.46B | 9.76B | 11.96B | 10.24B | 11.11B | 6.81B |
| Total Debt | 14.68B | 12.65B | 13.34B | 12.34B | 14.03B | 9.40B |
| Total Liabilities | 34.41B | 35.88B | 36.02B | 34.03B | 36.75B | 29.55B |
| Stockholders Equity | 42.86B | 46.75B | 43.18B | 40.04B | 36.28B | 34.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.46B | 3.88B | 1.48B | 775.40M | 2.85B |
| Operating Cash Flow | 0.00 | 4.96B | 4.56B | 2.12B | 1.09B | 3.02B |
| Investing Cash Flow | 0.00 | -4.17B | -3.37B | -1.39B | -1.49B | -1.37B |
| Financing Cash Flow | 0.00 | -3.03B | 436.00M | -2.11B | 4.19B | -2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥175.17B | 15.00 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥146.53B | 22.38 | ― | 1.79% | 7.03% | 26.11% | |
75 Outperform | ¥37.40B | 74.43 | ― | 4.12% | 3.07% | 41.55% | |
74 Outperform | ¥119.05B | 16.59 | ― | 2.66% | 0.19% | 9.62% | |
69 Neutral | ¥1.00T | 16.33 | 27.58% | 0.99% | 8.43% | 225.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥108.47B | -36.94 | 2.80% | 3.38% | -4.52% | -91.68% |